000 01143 a2200313 4500
005 20250517100618.0
264 0 _c20171107
008 201711s 0 0 eng d
022 _a1750-1172
024 7 _a10.1186/s13023-016-0455-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZelei, Tamás
245 0 0 _aSystematic review on the evaluation criteria of orphan medicines in Central and Eastern European countries.
_h[electronic resource]
260 _bOrphanet journal of rare diseases
_c06 2016
300 _a72 p.
_bdigital
500 _aPublication Type: Journal Article; Review; Systematic Review
650 0 4 _aCost-Benefit Analysis
650 0 4 _aDrug Costs
650 0 4 _aEurope
650 0 4 _aHumans
650 0 4 _aOrphan Drug Production
_xeconomics
650 0 4 _aRare Diseases
_xdrug therapy
650 0 4 _aTechnology Assessment, Biomedical
_xmethods
700 1 _aMolnár, Mária J
700 1 _aSzegedi, Márta
700 1 _aKaló, Zoltán
773 0 _tOrphanet journal of rare diseases
_gvol. 11
_gno. 1
_gp. 72
856 4 0 _uhttps://doi.org/10.1186/s13023-016-0455-6
_zAvailable from publisher's website
999 _c26088787
_d26088787